Advanced Prostate Cancer VL

Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab, Bisphosphonates and Radium-223 - Noel Clarke

Details
This video lecture presentations took place at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), in Lisbon, Portugal between in October 2016. The meeting was organised by Bioscript and the Scientific Committee, composed of Professors Laurence Klotz (Chair), Noel Clarke, Karim Fizazi and Bertrand Tombal. Noel Clarke, MD, discusses the biology of different bone targeted agents in metas...

Noel Clarke on Combination Treatment in Hormone-sensitive Prostate Cancer - STOP 6

Details
Combination Treatment in Hormone-sensitive Prostate Cancer (STOP 6) Biography: Noel Clarke, MD

Noel Clarke on Clinical applications of molecular genetics in prostate cancer - STOP 6

Details
Clinical applications of molecular genetics in prostate cancer (STOP 6) Biography: Noel Clarke, MD

Nicolas Mottet on EAU Guidelines for patients monitoring under treatment - STOP 6

Details
This video lecture presentations took place at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), in Lisbon, Portugal between in October 2016. The meeting was organised by Bioscript and the Scientific Committee, composed of Professors Laurence Klotz (Chair), Noel Clarke, Karim Fizazi and Bertrand Tombal. Nicolas Mottet presents a summary of the 2016 version of the European Association...

Nicolas Mottet on Managing the primary in elderly/unfit patients - STOP 6

Details
Managing the primary in elderly or unfit patients (STOP 6) Biography: Nicolas Mottet, MD, PhD

New Concepts in Androgen Deprivation Therapy (ADT) Agonists vs. Antagonists and All the Rest- Tom Keane

Details
Thomas Keane's video lecture is a state of the art review of personalized androgen deprivation therapy (ADT) for men being treated for advanced prostate cancer. This discussion includes the most recent data and considerations relative to identifying patients with cardiovascular disease, obesity and testosterone, fatty acid synthase (FSH) and adipogenous, high volume metastatic disease, use of doce...

Next-generation sequencing of prostate tumors: Use of individualised biomarkers for prognosis and treatment- Martin Spahn

Details
Next-generation sequencing of prostate tumors: Use of individualised biomarkers for prognosis and treatment (STOP 6) Biography: Martin Spahn, MD

Laurence Klotz on Active surveillance or: Shrinking the gray zone - STOP 6

Details
Active surveillance or Shrinking the gray zone (STOP 6) Biography: Laurence Klotz, MD

Karim Fizazi on Sequencing: Combination or individualized treatment - STOP 6

Details
Sequencing: Combination or individualized treatment (STOP 6) Biography: Karim Fizazi, MD

Karim Fizazi v. Bertrand Tombal on 'Hormone-naive metastatic prostate cancer patients should get chemotherapy and ADT as a standard of care' versus 'ADT and AR pathway-targeted agents still have a rol...

Details
Debate between Karim Fizazi and Bertrand Tombal on 'Hormone-naive metastatic prostate cancer patients should get chemotherapy and ADT as a standard of care' versus 'ADT and AR pathway-targeted agents still have a role in these patients’ (STOP 6) Biographies: Karim Fizazi, MD Bertrand Tombal, MD, PhD , us professor and Chairman, Service d'Urologie, Cliniques universitaires Saint Luc, Université cat...
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe